Teladoc Health Issues Inaugural Corporate Social Responsibility Report

    NEXT STORY
    Kaleido Biosciences Announces Positive Interim Results of Controlled Study of KB109 in Patients with Mild-to-Moderate COVID-19
    PREV STORY
    Organogenesis Enrolls First Patient in Pivotal Phase 3 Clinical Trial of RMAT-Designated ReNu® for Knee Osteoarthritis
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Cempra to Present Solithromycin IV Data at ATS 2016

    CHAPEL HILL, N.C., May 12, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage ...

    author_avatar
    NASDAQ Market News

    Retrophin Names Eric Dube, Ph.D. President and Chief Executive Officer

    Dr. Dube brings proven track record of global leadership built upon significant commercial and ...

    author_avatar
    NASDAQ Market News

    TESARO to Announce Third-Quarter 2018 Financial Results on November 1, 2018

    WALTHAM, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO) will announce ...

    author_avatar
    NASDAQ Market News